Literature DB >> 21601126

Hypertension and autosomal dominant polycystic kidney disease.

Robert W Schrier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21601126     DOI： 10.1053/j.ajkd.2011.02.379

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  8 in total

1.  Blood pressure in early autosomal dominant polycystic kidney disease.

Authors:  Robert W Schrier; Kaleab Z Abebe; Ronald D Perrone; Vicente E Torres; William E Braun; Theodore I Steinman; Franz T Winklhofer; Godela Brosnahan; Peter G Czarnecki; Marie C Hogan; Dana C Miskulin; Frederic F Rahbari-Oskoui; Jared J Grantham; Peter C Harris; Michael F Flessner; Kyongtae T Bae; Charity G Moore; Arlene B Chapman
Journal:  N Engl J Med       Date:  2014-11-15       Impact factor: 91.245

2.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

3.  Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Kaleab Z Abebe; Robert W Schrier; Ronald D Perrone; Arlene B Chapman; Alan S Yu; William E Braun; Theodore I Steinman; Godela Brosnahan; Marie C Hogan; Frederic F Rahbari; Jared J Grantham; Kyongtae T Bae; Charity G Moore; Michael F Flessner
Journal:  Kidney Int       Date:  2016-12-16       Impact factor: 10.612

Review 4.  New treatment paradigms for ADPKD: moving towards precision medicine.

Authors:  Matthew B Lanktree; Arlene B Chapman
Journal:  Nat Rev Nephrol       Date:  2017-10-09       Impact factor: 28.314

5.  Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression?

Authors:  Asmin Andries; Kristien Daenen; François Jouret; Bert Bammens; Djalila Mekahli; Ann Van Schepdael
Journal:  Pediatr Nephrol       Date:  2018-08-13       Impact factor: 3.714

6.  Endothelin 1 gene is not a major modifier of chronic kidney disease advancement among the autosomal dominant polycystic kidney disease patients.

Authors:  Shiva Nagendra Reddy Annapareddy; Ramprasad Elumalai; Bhaskar V K S Lakkakula; Gnanasambandan Ramanathan; Soundararajan Periyasamy
Journal:  J Nephropharmacol       Date:  2015-12-09

7.  The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition.

Authors:  Andrea Solazzo; Francesca Testa; Silvia Giovanella; Marco Busutti; Luciana Furci; Paola Carrera; Maurizio Ferrari; Giulia Ligabue; Giacomo Mori; Marco Leonelli; Gianni Cappelli; Riccardo Magistroni
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

8.  Combined renin-angiotensin-aldosterone system blockade and statin therapy effectively reduces the risk of cerebrovascular accident in autosomal dominant polycystic kidney disease: a nationwide population-based cohort study.

Authors:  Pei-Hsun Sung; Hsin-Ju Chiang; Mel S Lee; John Y Chiang; Hon-Kan Yip; Yao-Hsu Yang
Journal:  Oncotarget       Date:  2017-06-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.